We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    NCT01584076
Previous Study | Return to List | Next Study

Treatment of Residual Amblyopia With Donepezil

This study is currently recruiting participants.
Verified February 2017 by Carolyn Wu, Boston Children's Hospital
Sponsor:
ClinicalTrials.gov Identifier:
NCT01584076
First Posted: April 24, 2012
Last Update Posted: February 9, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Information provided by (Responsible Party):
Carolyn Wu, Boston Children's Hospital
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2018
  Estimated Primary Completion Date: June 2018 (Final data collection date for primary outcome measure)